Skip to main content
Retour
Watch Compare

Voyager Therapeutics, Inc.

Qualité des données : 100%
VYGR
Nasdaq Manufacturing Chemicals
3,97 €
▲ 0,05 € (1,28%)
Cap. Boursière: 236,61 M
Prix
3,97 €
Cap. Boursière
236,61 M
Fourchette du Jour
3,86 € — 4,01 €
Fourchette 52 Semaines
2,65 € — 5,55 €
Volume
367 638
Ouverture 3,89 €
Moyenne 50J / 200J
3,93 €
0,97% above
Moyenne 50J / 200J
3,95 €
0,43% above

Quick Summary

Points Clés

Revenue grew 1,92% annually over 5 years — modest growth
Negative free cash flow of -135,06 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 51,45%
Capital efficient — spends only 6,43% of revenue on capex

Croissance

Revenue Growth (5Y)
1,92%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)-49,53%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-51,63%
Au-dessus de la moyenne du secteur (-53,41%)
ROIC-39,09%
Net Margin-296,53%
Op. Margin-326,56%

Sécurité

Debt / Equity
N/A
Current Ratio6,19
Interest CoverageN/A

Valorisation

PE (TTM)
-1,98
En dessous de la moyenne du secteur (-1,48)
P/B Ratio1,08
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -2,0 -1,5
P/B 1,1 1,6
ROE % -51,6 -53,4
Net Margin % -296,5 -41,5
Rev Growth 5Y % 1,9 1,8
D/E — 0,3

ETFs Holding This Stock

EES logo EES WisdomTree U.S. SmallCap Fund
0,04% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,02% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,02% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0,00% weight
IWV logo IWV iShares Russell 3000 ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -49,53% Revenue Growth (3Y) -59,81%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 1,92% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 40,37 M Net Income (TTM) -119,72 M
ROE -51,63% ROA -39,23%
Gross Margin N/A Operating Margin -326,56%
Net Margin -296,53% Free Cash Flow (TTM) -135,06 M
ROIC -39,09% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6,19
Interest Coverage N/A Asset Turnover 0,13
Working Capital 184,09 M Tangible Book Value 219,83 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,98 Forward P/E N/A
P/B Ratio 1,08 P/S Ratio 5,86
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -57,08%
Market Cap 236,61 M Enterprise Value 191,48 M
Per Share
EPS (Diluted TTM) -2,04 Revenue / Share 0,68
FCF / Share -2,27 OCF / Share -2,22
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 6,43% FCF Conversion 112,81%
SBC-Adj. FCF -149,76 M Growth Momentum -51,45

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 40,37 M 80,00 M 250,01 M 40,91 M 37,42 M
Net Income -119,72 M -65,00 M 132,33 M -46,41 M -71,20 M
EPS (Diluted) -2,04 -1,13 2,97 -1,21 -1,89
Gross Profit — — — — —
Operating Income -131,84 M -83,29 M 122,01 M -50,84 M -73,62 M
EBITDA — — — — —
R&D Expenses 134,67 M 127,37 M 92,17 M 60,76 M 73,79 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 144 000,0 665 000,0 1,41 M 16 000,0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 252,28 M 393,05 M 351,28 M 159,36 M 193,86 M
Total Liabilities 56,20 M 93,29 M 114,96 M 100,34 M 98,80 M
Shareholders' Equity 196,08 M 299,76 M 236,32 M 59,02 M 95,06 M
Total Debt — — — — —
Cash & Equivalents 65,30 M 71,37 M 68,80 M 98,96 M 117,43 M
Current Assets 202,69 M 276,81 M 319,68 M 124,50 M 136,70 M
Current Liabilities 26,54 M 49,79 M 64,51 M 72,59 M 50,98 M